Daniel Mukasa

Excited for this next step! Reach out for more info

This is an insane list of speakers & attendees Professors (UCSF, Stanford, Arc, UW), investors (Lux, Menlo, KV, Dimension), VP+ at big pharma (GNE, Roche, Gilead, Abbvie, BMS, Novartis), and founders at the top AI for science companies... Unlock2026 is going to be sick.

it’s semaglutide patent cliff day for those who celebrate

Moderna was developing an EBV vaccine that had the potential to prevent MS and Lupus. That development project has now been shelved due to people at the FDA playing politics.

mRNA was the greatest medical advance of the century and then we're squandering it

nobody can convince me that this is not the definition of wealth, the ability to cancel all your plans, go to the gym for several hours and then cook something simple for dinner

For women / under-represented minorities applying to AI PhD programs this year: if you’d like feedback on your application, feel free to consider me a resource, particularly if you’re a non-traditional applicant. DMs open! (Paying it forward for the @WiMLworkshop community 💛)

A comprehensive talk on a very challenging topic. Thinking of two things: 1. Shall we skip structure and focus on function 2. Shall we focus on designing and optimising a single RNA family, ie, tRNAs btw, glad to see RiNALMo and AI4NA in the overview :)

AI × Bio Is Moving Fast — Don’t Get Left Behind. AI is transforming biology faster than ever; from foundation models that decode proteins and RNA, to intelligent systems designing new materials, medicines, and sustainable biomanufacturing processes. SynBioBeta is where the world’s leading researchers, investors, and builders in AI and biology will gather to define where this convergence goes next. If you’re working at the intersection of data, biology, or machine learning, this is where the critical conversations, partnerships, and breakthroughs are happening. From multimodal models that connect sequence to function to intelligent therapeutics that learn and adapt, AI is rewriting the rules of biology. If you’re not part of this conversation, you’re already behind. 🎟️ Save on tickets before prices increase on Friday October 31! Book before friday and enjoy a worry-free, full-refund policy if plans change. syntheticbiologysummit.com/?utm_source=so… See you May 4-7, 2026 at San Jose! Stay turned for more. 🚀 #AIxBIO #SynBioBeta #ProgrammableBiology #Biotech #TechBio #SyntheticBiology

as I get older, I have friends now leading some teams at companies and a big part of their job is dealing with company politics one common theme that's come up - there will always be people at companies who believe they can climb their way higher by pulling you down. The more senior and visible you are, the more this is true. Will will talk badly about your work, dunk on your leadership style, etc. to peers so they can potentially take your future responsibilities. This happens to every single person so don't take it personally when it happens to you. Personal beliefs: 1) The style of pulling people down burns enough bridges that eventually it backfires 2) The only thing that matters in the long run is that the people you respect, respect you. There will be people outside your sphere of influence that will probably hear the negative stuff. Just make sure the people you actually want to work with in the future respet you.

an absolute shame. @harvard cutting PhD admissions "The Organismic and Evolutionary Biology department will shrink its class size by roughly 75 percent to three new Ph.D. students [...] Molecular and Cellular Biology will reduce its figure to four new students, and Chemistry and Chemical Biology will go down to four or five admits" thecrimson.com/article/2025/1…

Boston = rigor but no vision & no execution SV = no rigor, but vision & execution

It is incredible to see how many @Caltech alumni that I’ve personally taught who are building their own startups. A truly gratifying feeling.

i'd never bet against Niki under any circumstances

No mention of Jeff Long and family is a bit disappointing...

AMERICAN CITIZENS who relied on H1-Bs to work here: Eric Yuan, Zoom founder Eren Bali, Udemy cofounder Sundar Pichai, Alphabet CEO Sanjay Mehrotra, Micron CEO Satya Nadella, Microsoft CEO Gustaf Alströmmer, YC Partner François Locoh-Donou, F5 CEO Andrew Ng, Coursera cofounder Indra Nooyi, former PepsiCo CEO Dheeraj Pandey, Nutanix founder Rahul Vohra, Superhuman founder Jyoti Bansal, AppDynamics founder Vinod Dham, “Father of the Pentium” Arif Janmohamed, Lightspeed partner Alfred Chuang, BEA Systems cofounder Farzad Dibachi, Inxeption co-founder & CEO Venkata Renduchintala, former Intel Chief Engineer

We're hiring! Our lab at the Ragon Institute of MGB, MIT, and Harvard is looking for a motivated postdoc with experience in developing and applying deep learning models. You'll work at the intersection of spatial transcriptomics and structural biology. #postdoc

📣 Check out our Antibody Developability Competition announcement with @huggingface here: huggingface.co/blog/ginkgo-da…, with up to $60k in prizes! 📷 Submissions close November 1st, 2025.

Legend David Baltimore died yesterday. He understood the way things should work: "the real contribution of @MIT is that it doesn't take itself too seriously. It takes ideas seriously, but the people are relatively informal. They are not self-aggrandizing the way academics can be.

Announcing our FIRST AI competition: Antibody Developability Prediction Ginkgo Datapoints and @huggingface are teaming up to create the first open benchmark for AI-driven antibody developability modeling, with up to $60k in prizes.